- Home
- DNN vs AVDL Comparison
DNN vs AVDL Comparison
Compare DNN & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- AVDL
- Stock Information
- Founded
- DNN 1954
- AVDL 2015
- Country
- DNN Canada
- AVDL Ireland
- Employees
- DNN N/A
- AVDL N/A
- Industry
- DNN Other Metals and Minerals
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- AVDL Health Care
- Exchange
- DNN Nasdaq
- AVDL Nasdaq
- Market Cap
- DNN 1.8B
- AVDL 1.8B
- IPO Year
- DNN 1997
- AVDL 1996
- Fundamental
- Price
- DNN $2.48
- AVDL $23.50
- Analyst Decision
- DNN
- AVDL Buy
- Analyst Count
- DNN 0
- AVDL 9
- Target Price
- DNN N/A
- AVDL $18.06
- AVG Volume (30 Days)
- DNN 80.5M
- AVDL 5.5M
- Earning Date
- DNN 11-06-2025
- AVDL 11-04-2025
- Dividend Yield
- DNN N/A
- AVDL N/A
- EPS Growth
- DNN N/A
- AVDL N/A
- EPS
- DNN N/A
- AVDL N/A
- Revenue
- DNN $3,493,456.00
- AVDL $248,517,000.00
- Revenue This Year
- DNN $197.71
- AVDL $64.21
- Revenue Next Year
- DNN $54.90
- AVDL $30.80
- P/E Ratio
- DNN N/A
- AVDL N/A
- Revenue Growth
- DNN 23.35
- AVDL 79.88
- 52 Week Low
- DNN $1.08
- AVDL $6.38
- 52 Week High
- DNN $3.42
- AVDL $23.56
- Technical
- Relative Strength Index (RSI)
- DNN 37.10
- AVDL 91.85
- Support Level
- DNN $2.54
- AVDL $18.74
- Resistance Level
- DNN $2.65
- AVDL $19.00
- Average True Range (ATR)
- DNN 0.16
- AVDL 0.25
- MACD
- DNN -0.06
- AVDL 0.20
- Stochastic Oscillator
- DNN 11.29
- AVDL 98.80
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.